Upon the release of information regarding the benefits of GLP-1 RAs in weight loss, news spread on social media about the medication that labels it as a simple way to lose weight
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes.New England Journal of Medicine 2021;385:503 15
We do have patients who are seeing results on lower doses. People taking semaglutide, he emphasized, really have to eat slow because [semaglutide] does affect the emptying of the stomach. Sometimes, people are taking these medications and eating like they did before
For most patients, teprotumumab appears to be disease-modulating temporarily lessening the disease but not disease-modifying changing the course of disease, says Dr
Risks During General Anesthesia and Deep Sedation GLP-1 agonists can delay gastric emptying, which can increase risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation
Studies by Ogata et al